In vivo drug target discovery: identifying the best targets from the genome
- PMID: 11849946
- DOI: 10.1016/s0958-1669(01)00271-3
In vivo drug target discovery: identifying the best targets from the genome
Abstract
A vast number of genes of unknown function threaten to clog drug discovery pipelines. To develop therapeutic products from novel genomic targets, it will be necessary to correlate biology with gene sequence information. Industrialized mouse reverse genetics is being used to determine gene function in the context of mammalian physiology and to identify the best targets for drug development.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
